Skip to content

A randomised controlled trial of the effects of reflexology on mood, coping and quality of life in women with early breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN87652313
Enrollment
180
Registered
2005-11-03
Start date
2002-04-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early breast cancer. Cancer Breast

Interventions

Intervention 1: self-initiated support in the Oncology Health Centres (treatment as usual) Intervention 2: self-initiated support in the Oncology Health Centres plus scalp massage (comparator physica

Sponsors

NHS Research and Development National Cancer Programme (UK)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Newly diagnosed early breast cancer (T1, T2 <3 cm, N0, N1a, M0).

Exclusion criteria

Exclusion criteria: 1. Unable to complete the study questionnaires 2. Unwilling to give written informed consent

Design outcomes

Primary

MeasureTime frame
The primary outcome measures will be patient acceptability (number of sessions of reflexology actually attended) and scores on the Clinical Trials Index derived from the Functional Assessment of Cancer Therapy: Breast Version (FACT-B) at week 18.

Secondary

MeasureTime frame
1. Mood Rating Scale (MRS) 2. Patient Satisfaction Questionnaire (PSQ) 3. FACT-B at week 24

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 1, 2026